A detailed history of Alpha Core Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Alpha Core Capital LLC holds 4,006 shares of AMGN stock, worth $1.18 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
4,006
Previous 3,536 13.29%
Holding current value
$1.18 Million
Previous $1.1 Million 16.85%
% of portfolio
0.3%
Previous 0.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $145,408 - $158,568
470 Added 13.29%
4,006 $1.29 Million
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $649,255 - $789,015
2,471 Added 232.02%
3,536 $1.1 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $286,346 - $345,656
1,065 New
1,065 $302,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $8,901 - $10,923
-45 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$182.24 - $241.7 $8,200 - $10,876
45 New
45 $9,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alpha Core Capital LLC Portfolio

Follow Alpha Core Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Core Capital LLC with notifications on news.